You are here

  • Home
  • Archive
  • Volume 9, Issue Suppl 2
  • 267 Dual checkpoint blockade of CD47 and PD-L1 using an affinity-tuned bispecific antibody maximizes anti-tumor immunity and improves therapeutic window

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Checkpoint Blockade Therapy
267 Dual checkpoint blockade of CD47 and PD-L1 using an affinity-tuned bispecific antibody maximizes anti-tumor immunity and improves therapeutic window
Free

 

Online download statistics by month:

Online download statistics by month: November 2021 to August 2024

AbstractFullPdf
Nov 2021313027
Dec 20215801
Jan 20225207
Feb 20225606
Mar 202225606
Apr 20228406
May 202236012
Jun 20221407
Jul 20222002
Aug 20225205
Sep 20221408
Oct 20221809
Nov 2022803
Dec 2022801
Jan 20231204
Feb 20231601
Mar 2023600
Apr 20231205
Jun 2023601
Jul 2023008
Aug 2023201
Sep 20231003
Oct 2023600
Nov 20231402
Dec 20232803
Jan 20241402
Feb 2024160881
Mar 20241805
Apr 2024803
May 20241400
Jun 2024600
Jul 2024602
Aug 2024802
Total119101023